-+ 0.00%
-+ 0.00%
-+ 0.00%

Rhythm Pharmaceuticals Reports Setmelanotide Significantly Reduces BMI in Hypothalamic Obesity Phase 3 Trial

Reuters·11/10/2025 12:01:14

Please log in to view news